Opportunity
CSS - Lab Equipment for Generation/Analysis
Response due
September 14, 2026
- Agency
- National Institutes of Health Olao
- Estimated value
- Not stated
(i) This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q01145. This solicitation is issued as a competitivecombined synopsis/solicitation for commercial products or commercial services. TheGovernment intends to award a contract or purchase order resulting from this solicitationusing full and open competition.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitationfor Commercial Products or Commercial Services, and is not expected to exceed thesimplified acquisition threshold.The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeksto award a firm-fixed-price purchase order to the responsible offeror whose proposalrepresents the best value to the Government.(iii) The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular 2026-01, effective 03/13/2026.(iv) The associated NAICS code is 334516 ¿ Analytical Laboratory InstrumentManufacturing, and the small business size standard is 1,000 employees.¿ This requirement is unrestricted.(v) Description of Requirement:The National Heart, Lung, and Blood Institute (NHLBI) requires the following commerciallyavailable laboratory equipment to support research on hematopoietic stem cell (HSC)-targeted lipid nanoparticle (LNP) gene delivery for the advancement of in vivo gene therapy.Offerors shall provide equipment meeting or exceeding the salient characteristics below.
Key dates
- Posted
- September 3, 2026
- Response due
- September 14, 2026
Who is this buyer
Organization
Buying history
- Records263 total
- Opportunities / awards10 / 20
- Value range$0 – $30,482,226
- ActiveJuly 15, 2026 – October 26, 2026
What they buy
- Clinical (251)
- Administrative (12)
Set-asides used
- No Set aside used (68)
- Small Business Set Aside - Total (14)
Who holds their work today
- EAGLE HEALTH, LLC1 win · $30,482,226 · last February 1, 2020
- LC INDUSTRIES INC1 win · $286,880 · last February 13, 2026
Also open from this buyer
- Clinical Research Support and Collaboration for NHGRI ProtocolsDue November 13, 2026 · Clinical
- NOI - 4D-Nucleofector Core Unit and X UnitDue November 5, 2026 · Clinical
- Reagents and consumables for Roche immunostainersDue October 28, 2026 · Clinical
- Combines Synopsis Solicitation- Automated SpatialDue November 5, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 334516
- PSC
- 6640